UBS assumed coverage of Comerica (CMA) with a Sell rating and $64 price target UBS sees below-Street pre-provision net revenue headwinds and limited optionality, the analyst tells investors in a research note.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.